Dysfunctions of the diffusional membrane pathways mediated hemichanels in inherited and acquired diseases

Current Vascular Pharmacology

Volumn 7, Issue 4, 2009, Pages 486-505

  Schalper, Kurt A ^a,b   Orellana, Juan A ^a,b   Berthoud, Viviana M ^c   Sáez, Juan C ^a,b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b Núcleo Milenio de Inmunología e Inmunoterapia ^*  (Chile)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Hemichannel; Human

Indexed keywords

CONNEXIN 26; CONNEXIN 30; CONNEXIN 31; CONNEXIN 32; CONNEXIN 36; CONNEXIN 37; CONNEXIN 40; CONNEXIN 43; CONNEXIN 46; CONNEXIN 47; GAP JUNCTION PROTEIN;

ATHEROSCLEROSIS; BACTERIAL INFECTION; CELL DEATH; CELL MEMBRANE; CELL PERMEABILIZATION; CHANNELOPATHY; CONGENITAL CATARACT; GENE MUTATION; GENETIC DISORDER; GENETIC POLYMORPHISM; HEARING IMPAIRMENT; HEREDITARY MOTOR SENSORY NEUROPATHY; HIDROTIC ECTODERMAL DYSPLASIA; HUMAN; INFLAMMATION; ION EXCHANGE; ISCHEMIA; MEMBRANE TRANSPORT; MUTANT; NONHUMAN; OCULODENTODIGITAL SYNDROME; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW;

ANIMALS; CELL MEMBRANE; COMMUNICABLE DISEASES; CONNEXINS; DIFFUSION; GENETIC DISEASES, INBORN; HUMANS; INFLAMMATION; ISCHEMIA; PROTEIN MULTIMERIZATION; SIGNAL TRANSDUCTION;

EID: 70349659631     PISSN: 15701611     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016109789043937     Document Type: Review

References (346)

1. Iovine MK, Gumpert AM, Falk MM, Mendelson TC. Cx23, a connexin with only four extracellular-loop cysteines, forms functional gap junction channels and hemichannels. FEBS Lett 2008; 582: 165-70.
2. Sáez JC, Berthoud VM, Brañes MC, Martínez AD, Beyer EC. Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev 2003; 83: 1359-400.
3. Eiberger J, Degen J, Romualdi A, Deutsch U, Willecke K, Söhl G. Connexin genes in the mouse and human genome. Cell Commun Adhes 2001; 8: 163-5.
4. Söhl G, Willecke K. Gap junctions and the connexin protein family. Cardiovasc Res 2004; 62: 228-32.
5. Evans WH, De Vuyst E, Leybaert L. The gap junction cellular internet: connexin hemichannels enter the signalling limelight. Biochem J 2006; 397: 1-14.
6. Herve JC. The connexins. Biochim Biophys Acta 2004; 1662: 1-2.
7. Laird DW. Life cycle of connexins in health and disease. Biochem J 2006; 394: 527-43.
8. Bruzzone R, White TW, Goodenough DA. The cellular Internet: on-line with connexins. Bioessays 1996; 18: 709-18.
9. Saffitz JE, Laing JG, Yamada KA. Connexin expression and turnover: implications for cardiac excitability. Circ Res 2000; 86: 723-8.
10. Berthoud VM, Minogue PJ, Laing JG, Beyer EC. Pathways for degradation of connexins and gap junctions. Cardiovasc Res 2004; 62: 256-67.
11. Berthoud VM, Bassnett S, Beyer EC. Cultured chicken embryo lens cells resemble differentiating fiber cells in vivo and contain two kinetic pools of connexin56. Exp Eye Res 1999; 68: 475-84.
12. Panchin Y, Kelmanson I, Matz M, Lukyanov K, Usman N, Lukyanov S. A ubiquitous family of putative gap junction molecules. Curr Biol 2000; 10: 473-4.
13. Bruzzone R, Hormuzdi SG, Barbe MT, Herb A, Monyer H. Pannexins, a family of gap junction proteins expressed in brain. Proc Natl Acad Sci USA 2003; 100: 13644-9.
14. Vanden Abeele F, Bidaux G, Gordienko D, Beck B, Panchin YV, Baranova AV, et al. Functional implications of calcium permeability of the channel formed by pannexin 1. J Cell Biol 2006; 174: 535-46.
15. Lai CP, Bechberger JF, Thompson RJ, MacVicar BA, Bruzzone R, Naus CC. Tumor-suppressive effects of pannexin 1 in C6 glioma cells. Cancer Res 2007; 67: 1545-54.
16. Barbe MT, Monyer H, Bruzzone R. Cell-cell communication beyond connexins: the pannexin channels. Physiology (Bethesda) 2006; 21: 103-14.
17. Boassa D, Ambrosi C, Qiu F, Dahl G, Gaietta G, Sosinsky G. Pannexin1 channels contain a glycosylation site that targets the hexamer to the plasma membrane. J Biol Chem 2007; 282: 31733-43.
18. Penuela S, Bhalla R, Gong XQ, Cowan KN, Celetti SJ, Cowan BJ, et al. Pannexin 1 and pannexin 3 are glycoproteins that exhibit many distinct characteristics from the connexin family of gap junction proteins. J Cell Sci 2007; 120: 3772-83.
19. Penuela S, Celetti SJ, Bhalla R, Shao Q, Laird DW. Diverse subcellular distribution profiles of pannexin 1 and pannexin 3. Cell Commun Adhes 2008; 15: 133142.
20. Litvin O, Tiunova A, Connell-Alberts Y, Panchin Y, Baranova A. What is hidden in the pannexin treasure trove: the sneak peek and the guesswork. J Cell Mol Med 2006; 10: 613-34.
21. 7 receptor. EMBO J 2006; 25: 5071-82.
22. Thompson RJ, Zhou N, MacVicar BA. Ischemia opens neuronal gap junction hemichannels. Science 2006; 312: 924-7.
23. Shestopalov VI, Panchin Y. Pannexins and gap junction protein diversity. Cell Mol Life Sci 2007.
24. 12/13 signalling in cardiomyocytes triggers pressure overload-induced cardiac fibrosis. EMBO J 2008; 27: 3104-15.
25. Musil LS, Goodenough DA. Biochemical analysis of connexin43 intracellular transport, phosphorylation, and assembly into gap junctional plaques. J Cell Biol 1991; 115: 1357-74.
26. Boassa D, Qiu F, Dahl G, Sosinsky G. Trafficking dynamics of glycosylated pannexin 1 proteins. Cell Commun Adhes 2008; 15: 119-32.
27. Shaw RM, Fay AJ, Puthenveedu MA, von Zastrow M, Jan YN, Jan LY. Microtubule plus-end-tracking proteins target gap junctions directly from the cell interior to adherens junctions. Cell 2007; 128: 547-560.
28. Lauf U, Giepmans BN, Lopez P, Braconnot S, Chen SC, Falk MM. Dynamic trafficking and delivery of connexons to the plasma membrane and accretion to gap junctions in living cells. Proc Natl Acad Sci USA 2002; 99: 10446-51.
29. Segretain D, Falk MM. Regulation of connexin biosynthesis, assembly, gap junction formation, and removal. Biochim Biophys Acta 2004; 1662: 3-21.
30. Jiang JX, Gu S. Gap junction- and hemichannel-independent actions of connexins. Biochim Biophys Acta 2005; 1711: 208-14.
31. Rodriguez-Sinovas A, Cabestrero A, Lopez D, Torre I, Morente M, Abellan A, et al. The modulatory effects of connexin 43 on cell death/ survival beyond cell coupling. Prog Biophys Mol Biol 2007; 94: 219-32.
32. DeVries SH, Schwartz EA. Hemi-gap-junction channels in solitary horizontal cells of the catfish retina. J Physiol 1992; 445: 201-30.
33. Paul DL, Ebihara L, Takemoto LJ, Swenson KI, Goodenough DA. Connexin46, a novel lens gap junction protein, induces voltage-gated currents in nonjunctional plasma membrane of Xenopus oocytes. J Cell Biol 1991; 115: 1077-89.
34. Retamal MA, Schalper KA, Shoji KF, Orellana JA, Bennett MV, Sáez JC. Possible involvement of different connexin43 domains in plasma membrane permeabilization induced by ischemia-reperfusion. J Membr Biol 2007; 218: 49-63.
35. González D, Gómez-Hernandez JM, Barrio LC. Species specificity of mammalian connexin-26 to form open voltage-gated hemichannels. FASEB J 2006; 20: 2329-38.
36. Plotkin LI, Manolagas SC, Bellido T. Transduction of cell survival signals by connexin-43 hemichannels. J Biol Chem 2002; 277:8648-8657.
37. John S, Cesario D, Weiss JN. Gap junctional hemichannels in the heart. Acta Physiol Scand 2003; 179: 23-31.
38. De Vuyst E, Decrock E, Cabooter L, Dubyak GR, Naus CC, Evans WH, Leybaert L. Intracellular calcium changes trigger connexin 32 hemichannel opening. EMBO J 2006; 25: 34-44.
39. i Responses. Mol Biol Cell 2008; 19: 3501-13.
40. Cherian PP, Siller-Jackson AJ, Gu S, Wang X, Bonewald LF, Sprague E, et al. Mechanical strain opens connexin 43 hemichannels in osteocytes: a novel mechanism for the release of prostaglandin. Mol Biol Cell 2005; 16: 3100-6.
41. Retamal MA, Schalper KA, Shoji KF, Bennett MV, Sáez JC. Opening of connexin 43 hemichannels is increased by lowering intracellular redox potential. Proc Natl Acad Sci USA 2007; 104: 8322-7.
42. Orellana JA, Sáez PJ, Shoji KF, Schalper KA, Palacios-Prado N, Velarde V, et al. Modulation of Brain hemichannels and Gap Junction Channels by Pro-Inflammatory Agents and Their Possible Role in Neurodegeneration. Antioxid Redox Signal 2009; 11: 369-99.
43. Cotrina ML, Lin JH, Alves-Rodrigues A, Liu S, Li J, Azmi-Ghadimi H, et al. Connexins regulate calcium signaling by controlling ATP release. Proc Natl Acad Sci USA 1998; 95: 15735-40.
44. Stout CE, Costantin JL, Naus CC, Charles AC. Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels. J Biol Chem 2002; 277: 10482-8.
45. Stout C, Charles A. Modulation of intercellular calcium signaling in astrocytes by extracellular calcium and magnesium. Glia 2003; 43: 265-73.
46. Gomes P, Srinivas SP, Van Driessche W, Vereecke J, Himpens B. ATP release through connexin hemichannels in corneal endothelial cells. Invest Ophthalmol Vis Sci 2005; 46: 1208-18.
47. Kang J, Kang N, Lovatt D, Torres A, Zhao Z, Lin J, et al. Connexin 43 hemichannels are permeable to ATP. J Neurosci 2008; 28: 4702-11.
48. + fluxes in intact cells. FASEB J 2001; 15: 10-2.
49. + and cyclic ADP-ribose in increasing intracellular calcium and enhancing cell proliferation of 3T3 fibroblasts. J Biol Chem 2001; 276: 21642-8.
50. Ahmad S, Evans WH. Post-translational integration and oligomerization of connexin 26 in plasma membranes and evidence of formation of membrane pores: implications for the assembly of gap junctions. Biochem J 2002; 365: 693-9.
51. Siller-Jackson AJ, Burra S, Gu S, Xia X, Bonewald LF, Sprague E, et al. Adaptation of connexin 43-hemichannel prostaglandin release to mechanical loading. J Biol Chem 2008; 283: 26374-82.
52. Ye ZC, Wyeth MS, Baltan-Tekkok S, Ransom BR. Functional hemichannels in astrocytes: a novel mechanism of glutamate release. J Neurosci 2003; 23: 3588-96.
53. Rana S, Dringen R. Gap junction hemichannel-mediated release of glutathione from cultured rat astrocytes. Neurosci Lett 2007; 415: 45-8.
54. Retamal MA, Froger N, Palacios-Prado N, Ezan P, Sáez PJ, Sáez JC, et al. Cx43 hemichannels and gap junction channels in astrocytes are regulated oppositely by proinflammatory cytokines released from activated microglia. J Neurosci 2007; 27: 13781-92.
55. Sáez JC, Contreras JE, Bukauskas FF, Retamal MA, Bennett MV. Gap junction hemichannels in astrocytes of the CNS. Acta Physiol Scand 2003; 179: 9-22.
56. Pearson RA, Dale N, Llaudet E, Mobbs P. ATP released via gap junction hemichannels from the pigment epithelium regulates neural retinal progenitor proliferation. Neuron 2005; 46: 731-44.
57. Quist AP, Rhee SK, Lin H, Lal R. Physiological role of gap-junctional hemichannels. Extracellular calcium-dependent isosmotic volume regulation. J Cell Biol 2000; 148: 1063-74.
58. Kamermans M, Fahrenfort I, Schultz K, Janssen-Bienhold U, Sjoerdsma T, Weiler R. Hemichannel-mediated inhibition in the outer retina. Science 2001; 292: 1178-80.
59. Spray DC, Ye ZC, Ransom BR. Functional connexin "hemichannels": a critical appraisal. Glia 2006; 54: 758-73.
60. Wang J, Ma M, Locovei S, Keane RW, Dahl G. Modulation of membrane channel currents by gap junction protein mimetic peptides: size matters. Am J Physiol Cell Physiol 2007; 293: 1112-9.
61. Harris AL. Connexin channel permeability to cytoplasmic molecules. Prog Biophys Mol Biol 2007; 94: 120-43.
62. White TW, Paul DL. Genetic diseases and gene knockouts reveal diverse connexin functions. Annu Rev Physiol 1999; 61: 283-310.
63. Gerido DA, White TW. Connexin disorders of the ear, skin, and lens. Biochim Biophys Acta 2004; 1662: 159-70.
64. Pagarkar W, Bitner-Glindzicz M, Knight J, Sirimanna T. Late postnatal onset of hearing loss due to GJB2 mutations. Int J Pediatr Otorhinolaryngol 2006; 70: 1119-24.
65. Boerma M, Forsberg L, Van Zeijl L, Morgenstern R, De Faire U, Lemne C, et al. A genetic polymorphism in connexin 37 as a prognostic marker for atherosclerotic plaque development. J Intern Med 1999; 246: 211-8.
66. Firouzi M, Ramanna H, Kok B, Jongsma HJ, Koeleman BP, Doevendans PA, et al. Association of human connexin40 gene polymorphisms with atrial vulnerability as a risk factor for idiopathic atrial fibrillation. Circ Res 2004; 95: 29-33.
67. Firouzi M, Kok B, Spiering W, Busjahn A, Bezzina CR, Ruijter JM, et al. Polymorphisms in human connexin40 gene promoter are associated with increased risk of hypertension in men. J Hypertens 2006; 24: 325-30.
68. Hauer RN, Groenewegen WA, Firouzi M, Ramanna H, Jongsma HJ. Cx40 polymorphism in human atrial fibrillation. Adv Cardiol 2006; 42: 284-91.
69. Abrams CK, Oh S, Ri Y, Bargiello TA. Mutations in connexin 32: the molecular and biophysical bases for the X-linked form of Charcot-Marie-Tooth disease. Brain Res Brain Res Rev 2000; 32: 203-14.
70. Nave KA, Sereda MW, Ehrenreich H. Mechanisms of disease: inherited demyelinating neuropathies - from basic to clinical research. Nat Clin Pract Neurol 2007; 3: 453-64.
71. Burns J, Ouvrier RA, Nicholson GA, Ryan MM. Establishment of the Australasian paediatric Charcot-Marie-Tooth disease registry. Neuromuscul Disord 2007; 17: 349-50.
72. Panas M, Karadimas C, Avramopoulos D, Vassilopoulos D. Central nervous system involvement in four patients with Charcot-Marie-Tooth disease with connexin 32 extracellular mutations. J Neurol Neurosurg Psychiatry 1998; 65: 947-8.
73. Martyn CN, Hughes RA. Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry 1997; 62: 310-8.
74. Shy ME, Siskind C, Swan ER, Krajewski KM, Doherty T, Fuerst DR, et al. CMT1X phenotypes represent loss of GJB1 gene function. Neurology 2007; 68: 849-55.
75. Scherer SS, Deschenes SM, Xu YT, Grinspan JB, Fischbeck KH, Paul DL. Connexin32 is a myelin-related protein in the PNS and CNS. J Neurosci 1995; 15: 8281-94.
76. Oh S, Ri Y, Bennett MV, Trexler EB, Verselis VK, Bargiello TA. Changes in permeability caused by connexin 32 mutations underlie X-linked Charcot-Marie-Tooth disease. Neuron 1997; 19: 927-38.
77. Castro C, Gomez-Hernandez JM, Silander K, Barrio LC. Altered formation of hemichannels and gap junction channels caused by C-terminal connexin-32 mutations. J Neurosci 1999; 19: 3752-60.
78. Abrams CK, Bennett MV, Verselis VK, Bargiello TA. Voltage opens unopposed gap junction hemichannels formed by a connexin 32 mutant associated with X-linked Charcot-Marie-Tooth disease. Proc Natl Acad Sci USA 2002; 99: 3980-4.
79. Liang GS, de Miguel M, Gomez-Hernandez JM, Glass JD, Scherer SS, Mintz M, et al. Severe neuropathy with leaky connexin-32 hemichannels. Ann Neurol 2005; 57: 749-54.
80. Gomez-Hernandez JM, de Miguel M, Larrosa B, Gonzalez D, Barrio LC. Molecular basis of calcium regulation in connexin-32 hemichannels. Proc Natl Acad Sci USA 2003; 100: 16030-5.
81. Paznekas WA, Boyadjiev SA, Shapiro RE, Daniels O, Wollnik B, Keegan CE, et al. Connexin 43 (GJA1) mutations cause the pleiotropic phenotype of oculodentodigital dysplasia. Am J Hum Genet 2003; 72: 408-18.
82. Vitiello C, D'Adamo P, Gentile F, Vingolo EM, Gasparini P, Banfi S. A novel GJA1 mutation causes oculodentodigital dysplasia without syndactyly. Am J Med Genet A 2005; 133: 58-60.
83. Loddenkemper T, Grote K, Evers S, Oelerich M, Stogbauer F. Neurological manifestations of the oculodentodigital dysplasia syndrome. J Neurol 2002; 249: 584-95.
84. Kjaer KW, Hansen L, Eiberg H, Leicht P, Opitz JM, Tommerup N. Novel Connexin 43 (GJA1) mutation causes oculo-dento-digital dysplasia with curly hair. Am J Med Genet A 2004; 127A: 152-7.
85. Lai A, Le DN, Paznekas WA, Gifford WD, Jabs EW, Charles AC. Oculodentodigital dysplasia connexin43 mutations result in nonfunctional connexin hemichannels and gap junctions in C6 glioma cells. J Cell Sci 2006; 119: 532-41.
86. Dobrowolski R, Sommershof A, Willecke K. Some oculodentodigital dysplasia-associated Cx43 mutations cause increased hemichannel activity in addition to deficient gap junction channels. J Membr Biol 2007; 219: 9-17.
87. Bao X, Altenberg GA, Reuss L. Mechanism of regulation of the gap junction protein connexin 43 by protein kinase C-mediated phosphorylation. Am J Physiol Cell Physiol 2004; 286: 647-54.
88. Kim DY, Kam Y, Koo SK, Joe CO. Gating connexin 43 channels reconstituted in lipid vesicles by mitogen-activated protein kinase phosphorylation. J Biol Chem 1999; 274: 5581-7.
89. Romanello M, Veronesi V, D'Andrea P. Mechanosensitivity and intercellular communication in HOBIT osteoblastic cells: a possible role for gap junction hemichannels. Biorheology 2003; 40: 119-21.
90. van Kempen MJ, Fromaget C, Gros D, Moorman AF, Lamers WH. Spatial distribution of connexin43, the major cardiac gap junction protein, in the developing and adult rat heart. Circ Res 1991; 68: 1638-51.
91. Davis LM, Kanter HL, Beyer EC, Saffitz JE. Distinct gap junction protein phenotypes in cardiac tissues with disparate conduction properties. J Am Coll Cardiol 1994; 24: 1124-32.
92. Reaume AG, de Sousa PA, Kulkarni S, Langille BL, Zhu D, Davies TC, et al. Cardiac malformation in neonatal mice lacking connexin43. Science 1995; 267: 1831-4.
93. Guerrero PA, Schuessler RB, Davis LM, Beyer EC, Johnson CM, Yamada KA, et al. Slow ventricular conduction in mice heterozygous for a connexin43 null mutation. J Clin Invest 1997; 99: 1991-8.
94. Thomas SA, Schuessler RB, Berul CI, Beardslee MA, Beyer EC, Mendelsohn ME, et al. Disparate effects of deficient expression of connexin43 on atrial and ventricular conduction: evidence for chamber-specific molecular determinants of conduction. Circulation 1998; 97: 686-91.
95. Gutstein DE, Morley GE, Tamaddon H, Vaidya D, Schneider MD, Chen J, et al. Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ Res 2001; 88: 333-9.
96. Beyer EC, Kistler J, Paul DL, Goodenough DA. Antisera directed against connexin43 peptides react with a 43-kD protein localized to gap junctions in myocardium and other tissues. J Cell Biol 1989; 108: 595-605.
97. Gao Y, Spray DC. Structural changes in lenses of mice lacking the gap junction protein connexin43. Invest Ophthalmol Vis Sci 1998; 39: 1198-209.
98. Sohl G, Guldenagel M, Traub O, Willecke K. Connexin expression in the retina. Brain Res Brain Res Rev 2000; 32: 138-45.
99. White TW, Sellitto C, Paul DL, Goodenough DA. Prenatal lens development in connexin43 and connexin50 double knockout mice. Invest Ophthalmol Vis Sci 2001; 42: 2916-23.
100. Gong X, Li E, Klier G, Huang Q, Wu Y, Lei H, et al. Disruption of α3 connexin gene leads to proteolysis and cataractogenesis in mice. Cell 1997; 91: 833-43.
101. White TW, Goodenough DA, Paul DL. Targeted ablation of connexin50 in mice results in microphthalmia and zonular pulverulent cataracts. J Cell Biol 1998; 143: 815-25.
102. Rong P, Wang X, Niesman I, Wu Y, Benedetti LE, Dunia I, et al. Disruption of Gja8 (α8 connexin) in mice leads to microphthalmia associated with retardation of lens growth and lens fiber maturation. Development 2002; 129: 167-74.
103. Kikuchi T, Kimura RS, Paul DL, Adams JC. Gap junctions in the rat cochlea: immunohistochemical and ultrastructural analysis. Anat Embryol (Berl) 1995; 191: 101-18.
104. Forge A, Becker D, Casalotti S, Edwards J, Evans WH, Lench N, et al. Gap junctions and connexin expression in the inner ear. Novartis Found Symp 1999; 219: 134-50; discussion 151-36.
105. Forge A, Marziano NK, Casalotti SO, Becker DL, Jagger D. The inner ear contains heteromeric channels composed of cx26 and cx30 and deafness-related mutations in cx26 have a dominant negative effect on cx30. Cell Commun Adhes 2003; 10: 341-6.
106. Zhao HB, Kikuchi T, Ngezahayo A, White TW. Gap junctions and cochlear homeostasis. J Memb Biol 2006; 209: 177-86.
107. 3 in a mutant connexin underlies recessive hereditary deafness. Nat Cell Biol 2005; 7: 63-9.
108. Zhang Y, Tang W, Ahmad S, Sipp JA, Chen P, Lin X. Gap junction-mediated intercellular biochemical coupling in cochlear supporting cells is required for normal cochlear functions. Proc Natl Acad Sci USA 2005; 102: 15201-6.
109. Oguchi T, Ohtsuka A, Hashimoto S, Oshima A, Abe S, Kobayashi Y, et al. Clinical features of patients with GJB2 (connexin 26) mutations: severity of hearing loss is correlated with genotypes and protein expression patterns. J Hum Genet 2005; 50: 76-83.
110. Chen Y, Deng Y, Bao X, Reuss L, Altenberg GA. Mechanism of the defect in gap-junctional communication by expression of a connexin 26 mutant associated with dominant deafness. FASEB J 2005; 19: 1516-8.
111. Stong BC, Chang Q, Ahmad S, Lin X. A novel mechanism for connexin 26 mutation linked deafness: cell death caused by leaky gap junction hemichannels. Laryngoscope 2006; 116: 2205-10.
112. Gerido DA, DeRosa AM, Richard G, White TW. Aberrant hemichannel properties of Cx26 mutations causing skin disease and deafness. Am J Physiol Cell Physiol 2007; 293: 337-45.
113. Kibar Z, Dube MP, Powell J, McCuaig C, Hayflick SJ, Zonana J, et al. Clouston hidrotic ectodermal dysplasia (HED): genetic homogeneity, presence of a founder effect in the French Canadian population and fine genetic mapping. Eur J Hum Genet 2000; 8: 372-80.
114. Fraser FC, Der Kaloustian VM. A man, a syndrome, a gene: Clouston's hidrotic ectodermal dysplasia (HED). Am J Med Genet 2001; 100: 164-8.
115. Radhakrishna U, Blouin JL, Mehenni H, Mehta TY, Sheth FJ, Sheth JJ, et al. The gene for autosomal dominant hidrotic ectodermal dysplasia (Clouston syndrome) in a large Indian family maps to the 13q11-q12.1 pericentromeric region. Am J Med Genet 1997; 71: 80-6.
116. Lamartine J, Munhoz Essenfelder G, Kibar Z, Lanneluc I, Callouet E, Laoudj D, et al. Mutations in GJB6 cause hidrotic ectodermal dysplasia. Nat Genet 2000; 26: 142-4.
117. Smith FJ, Morley SM, McLean WH. A novel connexin 30 mutation in Clouston syndrome. J Invest Dermatol 2002; 118: 530-2.
118. Essenfelder GM, Bruzzone R, Lamartine J, Charollais A, Blanchet-Bardon C, Barbe MT, et al. Connexin30 mutations responsible for hidrotic ectodermal dysplasia cause abnormal hemichannel activity. Hum Mol Genet 2004; 13: 1703-14.
119. Mathias RT, Rae JL. The lens: local transport and global transparency. Exp Eye Res 2004; 78: 689-98.
120. Musil LS, Beyer EC, Goodenough DA. Expression of the gap junction protein connexin43 in embryonic chick lens: molecular cloning, ultrastructural localization, and post-translational phosphorylation. J Membr Biol 1990; 116: 163-75.
121. TenBroek EM, Johnson R, Louis CF. Cell-to-cell communication in a differentiating ovine lens culture system. Invest Ophthalmol Vis Sci 1994; 35: 215-28.
122. White TW, Bruzzone R, Goodenough DA, Paul DL. Mouse Cx50, a functional member of the connexin family of gap junction proteins, is the lens fiber protein MP70. Mol Biol Cell 1992; 3: 711-20.
123. Puk O, Loster J, Dalke C, Soewarto D, Fuchs H, Budde B, et al. Mutation in a novel connexin-like gene (Gjf1) in the mouse affects early lens development and causes a variable small-eye phenotype. Invest Ophthalmol Vis Sci 2008; 49: 1525-32.
124. Sonntag S, Sohl G, Dobrowolski R, Zhang J, Theis M, Winterhager E, et al. Mouse lens connexin23 (Gje1) does not form functional gap junction channels but causes enhanced ATP release from HeLa cells. Eur J Cell Biol 2008; In press.
125. Steele EC, Jr., Lyon MF, Favor J, Guillot PV, Boyd Y, Church RL. A mutation in the connexin 50 (Cx50) gene is a candidate for the No2 mouse cataract. Curr Eye Res 1998; 17: 883-9.
126. Graw J, Loster J, Soewarto D, Fuchs H, Meyer B, Reis A, et al. Characterization of a mutation in the lens-specific MP70 encoding gene of the mouse leading to a dominant cataract. Exp Eye Res 2001; 73: 867-76.
127. Runge PE, Hawes NL, Heckenlively JR, Langley SH, Roderick TH. Autosomal dominant mouse cataract (Lop-10). Consistent differences of expression in heterozygotes. Invest Ophthalmol Vis Sci 1992; 33: 3202-8.
128. Chang B, Wang X, Hawes NL, Ojakian R, Davisson MT, Lo WK, et al. A Gja8 (Cx50) point mutation causes an alteration of α 3 connexin (Cx46) in semi-dominant cataracts of Lop10 mice. Hum Mol Genet 2002; 11: 507-13.
129. Berthoud VM, Beyer EC. Oxidative Stress, Lens Gap Junctions, and Cataracts. Antioxid Redox Signal 2008; In press.
130. Berthoud VM, Minogue PJ, Guo J, Williamson EK, Xu X, Ebihara L, et al. Loss of function and impaired degradation of a cataract-associated mutant connexin50. Eur J Cell Biol 2003; 82: 209-21.
131. Minogue PJ, Liu X, Ebihara L, Beyer EC, Berthoud VM. An aberrant sequence in a connexin46 mutant underlies congenital cataracts. J Biol Chem 2005; 280: 40788-95.
132. Arora A, Minogue PJ, Liu X, Reddy MA, Ainsworth JR, Bhattacharya SS, et al. A novel GJA8 mutation is associated with autosomal dominant lamellar pulverulent cataract: further evidence for gap junction dysfunction in human cataract. J Med Genet 2006; 43: 2.
133. Pal JD, Berthoud VM, Beyer EC, Mackay D, Shiels A, Ebihara L. Molecular mechanism underlying a Cx50-linked congenital cataract. Am J Physiol 1999; 276: 1443-6.
134. Pal JD, Liu X, Mackay D, Shiels A, Berthoud VM, Beyer EC, et al. Connexin46 mutations linked to congenital cataract show loss of gap junction channel function. Am J Physiol Cell Physiol 2000; 279: 596-602.
135. Shibayama J, Paznekas W, Seki A, Taffet S, Jabs EW, Delmar M, et al. Functional characterization of connexin43 mutations found in patients with oculodentodigital dysplasia. Circ Res 2005; 96: -91.
136. Ebihara L, Steiner E. Properties of a nonjunctional current expressed from a rat connexin46 cDNA in Xenopus oocytes. J Gen Physiol 1993; 102: 59-74.
137. Zampighi GA, Loo DD, Kreman M, Eskandari S, Wright EM. Functional and morphological correlates of connexin50 expressed in Xenopus laevis oocytes. J Gen Physiol 1999; 113: 507-24.
138. Ebihara L, Berthoud VM, Beyer EC. Distinct behavior of connexin56 and connexin46 gap junctional channels can be predicted from the behavior of their hemi-gap-junctional channels. Biophys J 1995; 68: 1796-803.
139. Pfahnl A, Dahl G. Gating of cx46 gap junction hemichannels by calcium and voltage. Pflügers Arch 1999; 437:345-53.
140. Beahm DL, Hall JE. Hemichannel and junctional properties of connexin 50. Biophys J 2002;82:2016-2031.
141. Trexler EB, Bennett MV, Bargiello TA, Verselis VK. Voltage gating and permeation in a gap junction hemichannel. Proc Natl Acad Sci USA 1996; 93: 5836-41.
142. Valiunas V, Weingart R. Electrical properties of gap junction hemichannels identified in transfected HeLa cells. Pflügers Arch 2000; 440: 366-79.
143. Zhang X, Zou T, Liu Y, Qi Y. The gating effect of calmodulin and calcium on the connexin50 hemichannel. Biol Chem 2006; 387: 595-601.
144. Ngezahayo A, Zeilinger C, Todt II, Marten II, Kolb H. Inactivation of expressed and conducting rCx46 hemichannels by phosphorylation. Pflugers Arch 1998; 436: 627-9.
145. Jiang JX, Goodenough DA. Heteromeric connexons in lens gap junction channels. Proc Natl Acad Sci USA 1996; 93: 1287-91.
146. Ebihara L, Xu X, Oberti C, Beyer EC, Berthoud VM. Co-expression of lens fiber connexins modifies hemi-gap-junctional channel behavior. Biophys J 1999; 76: 198-206.
147. Bao L, Sachs F, Dahl G. Connexins are mechanosensitive. Am J Physiol Cell Physiol 2004; 287: 1389-95.
148. Ebihara L, Liu X, Pal JD. Effect of external magnesium and calcium on human connexin46 hemichannels. Biophys J 2003; 84: 277-86.
149. Eckert R, Donaldson P, Goldie K, Kistler J. A distinct membrane current in rat lens fiber cells isolated under calcium-free conditions. Invest Ophthalmol Vis Sci 1998; 39: 1280-5.
150. Retamal MA, Cortés CJ, Reuss L, Bennett MV, Sáez JC. S-nitrosylation and permeation through connexin 43 hemichannels in astrocytes: induction by oxidant stress and reversal by reducing agents. Proc Natl Acad Sci USA 2006; 103: 4475-80.
151. Dvoriantchikova G, Ivanov D, Pestova A, Shestopalov V. Molecular characterization of pannexins in the lens. Mol Vis 2006; 12: 1417-26.
152. Dobrowolski R, Willecke K. Connexin-caused genetic diseases and corresponding mouse models. Antioxid Redox Signal 2008; In press.
153. John SA, Kondo R, Wang SY, Goldhaber JI, Weiss JN. Connexin-43 hemichannels opened by metabolic inhibition. J Biol Chem 1999; 274: 236-40.
154. Kondo RP, Wang SY, John SA, Weiss JN, Goldhaber JI. Metabolic inhibition activates a non-selective current through connexin hemichannels in isolated ventricular myocytes. J Mol Cell Cardiol 2000; 32: 1859-72.
155. i in rabbit ventricular myocytes during metabolic inhibition. J Mol Cell Cardiol 2001; 33: 2145-55.
156. Contreras JE, Sánchez HA, Eugenín EA, Speidel D, Theis M, Willecke K, et al. Metabolic inhibition induces opening of unapposed connexin 43 gap junction hemichannels and reduces gap junctional communication in cortical astrocytes in culture. Proc Natl Acad Sci USA 2002; 99: 495-500.
157. Contreras JE, Sánchez HA, Veliz LP, Bukauskas FF, Bennett MV, Sáez JC. Role of connexin-based gap junction channels and hemichannels in ischemia-induced cell death in nervous tissue. Brain Res Brain Res Rev 2004; 47: 290-303.
158. Shintani-Ishida K, Uemura K, Yoshida K. Hemichannels in cardiomyocytes open transiently during ischemia and contribute to reperfusion injury following brief ischemia. Am J Physiol Heart Circ Physiol 2007; 293: 1714-20.
159. Zhang L, Deng T, Sun Y, Liu K, Yang Y, Zheng X. Role for nitric oxide in permeability of hippocampal neuronal hemichannels during oxygen glucose deprivation. J Neurosci Res 2008; 86: 2281-91.
160. Vergara L, Bao X, Cooper M, Bello-Reuss E, Reuss L. Gap-junctional hemichannels are activated by ATP depletion in human renal proximal tubule cells. J Membr Biol 2003; 196: 173-84.
161. + and cellular energy. Circ Res 1995; 77: 394-406.
162. 23Na NMR demonstrates prolonged increase of intracellular sodium following transient regional ischemia in the in situ pig heart. Basic Res Cardiol 1999; 94: 60-9.
163. 2+ handling of smooth muscle cells in aorta of apolipoprotein E-deficient mice before development of atherosclerotic lesions. Cell Calcium 2007; 41: 295-302.
164. Bukauskas FF, Kreuzberg MM, Rackauskas M, Bukauskiene A, Bennett MV, Verselis VK, et al. Properties of mouse connexin 30.2 and human connexin 31.9 hemichannels: implications for atrioventricular conduction in the heart. Proc Natl Acad Sci USA 2006; 103: 9726-31.
165. De Vuyst E, Decrock E, De Bock M, Yamasaki H, Naus CC, Evans WH, et al. Connexin hemichannels and gap junction channels are differentially influenced by lipopolysaccharide and basic fibroblast growth factor. Mol Biol Cell 2007; 18: 34-46.
166. Warth A, Eckle T, Kohler D, Faigle M, Zug S, Klingel K, et al. Upregulation of the water channel aquaporin-4 as a potential cause of postischemic cell swelling in a murine model of myocardial infarction. Cardiology 2007; 107: 402-10.
167. Kimelberg HK. Astrocytic swelling in cerebral ischemia as a possible cause of injury and target for therapy. Glia 2005; 50: 389-97.
168. Rawanduzy A, Hansen A, Hansen TW, Nedergaard M. Effective reduction of infarct volume by gap junction blockade in a rodent model of stroke. J Neurosurg 1997; 87: 916-20.
169. Nakase T, Fushiki S, Sohl G, Theis M, Willecke K, Naus CC. Neuroprotective role of astrocytic gap junctions in ischemic stroke. Cell Commun Adhes 2003; 10: 413-7.
170. Nakase T, Sohl G, Theis M, Willecke K, Naus CC. Increased apoptosis and inflammation after focal brain ischemia in mice lacking connexin43 in astrocytes. Am J Pathol 2004; 164: 2067-75.
171. Siushansian R, Bechberger JF, Cechetto DF, Hachinski VC, Naus CC. Connexin43 null mutation increases infarct size after stroke. J Comp Neurol 2001; 440: 387-94.
172. Perez Velazquez JL, Kokarovtseva L, Sarbaziha R, Jeyapalan Z, Leshchenko Y. Role of gap junctional coupling in astrocytic networks in the determination of global ischaemia-induced oxidative stress and hippocampal damage. Eur J Neurosci 2006; 23: 1-10.
173. Oguro K, Jover T, Tanaka H, Lin Y, Kojima T, Oguro N, et al. Global ischemia-induced increases in the gap junctional proteins connexin 32 (Cx32) and Cx36 in hippocampus and enhanced vulnerability of Cx32 knock-out mice. J Neurosci 2001; 21: 7534-42.
174. Takeuchi H, Jin S, Wang J, Zhang G, Kawanokuchi J, Kuno R, et al. Tumor necrosis factor-α induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J Biol Chem 2006; 281: 21362-8.
175. Garcia-Dorado D, Inserte J, Ruiz-Meana M, Gonzalez MA, Solares J, Julia M, et al. Gap junction uncoupler heptanol prevents cell-to-cell progression of hypercontracture and limits necrosis during myocardial reperfusion. Circulation 1997; 96: 3579-86.
176. Schulz R, Gres P, Skyschally A, Duschin A, Belosjorow S, Konietzka I, et al. Ischemic preconditioning preserves connexin 43 phosphorylation during sustained ischemia in pig hearts in vivo. FASEB J 2003; 17: 1355-7.
177. Beardslee MA, Lerner DL, Tadros PN, Laing JG, Beyer EC, Yamada KA, et al. Dephosphorylation and intracellular redistribution of ventricular connexin43 during electrical uncoupling induced by ischemia. Circ Res 2000; 87: 656-62.
178. Jain SK, Schuessler RB, Saffitz JE. Mechanisms of delayed electrical uncoupling induced by ischemic preconditioning. Circ Res 2003; 92: 1138-44.
179. Miura T, Ohnuma Y, Kuno A, Tanno M, Ichikawa Y, Nakamura Y, et al. Protective role of gap junctions in preconditioning against myocardial infarction. Am J Physiol Heart Circ Physiol 2004; 286: 214-21.
180. Cotrina ML, Kang J, Lin JH, Bueno E, Hansen TW, He L, et al. Astrocytic gap junctions remain open during ischemic conditions. J Neurosci 1998; 18: 2520-37.
181. Doble BW, Chen Y, Bosc DG, Litchfield DW, Kardami E. Fibroblast growth factor-2 decreases metabolic coupling and stimulates phosphorylation as well as masking of connexin43 epitopes in cardiac myocytes. Circ Res 1996; 79: 647-58.
182. Jiang ZS, Padua RR, Ju H, Doble BW, Jin Y, Hao J, et al. Acute protection of ischemic heart by FGF-2: involvement of FGF-2 receptors and protein kinase C. Am J Physiol Heart Circ Physiol 2002; 282: 1071-80.
183. Htun P, Ito WD, Hoefer IE, Schaper J, Schaper W. Intramyocardial infusion of FGF-1 mimics ischemic preconditioning in pig myocardium. J Mol Cell Cardiol 1998; 30: 867-77.
184. Lin JH, Lou N, Kang N, Takano T, Hu F, Han X, et al. A central role of connexin 43 in hypoxic preconditioning. J Neurosci 2008; 28: 681-95.
185. Schock SC, Leblanc D, Hakim AM, Thompson CS. ATP release by way of connexin 36 hemichannels mediates ischemic tolerance in vitro. Biochem Biophys Res Commun 2008; 368: 138-44.
186. Boengler K, Dodoni G, Rodriguez-Sinovas A, Cabestrero A, Ruiz-Meana M, Gres P, et al. Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning. Cardiovasc Res 2005; 67: 234-44.
187. Nakashima Y, Kohno H, ON EL-A, Dhar DK, Ono T, Yamanoi A, et al. Sequential changes of connexin32 and connexin26 in ischemia-reperfusion of the liver in rats. Hepatol Res 2003; 27: 67-75.
188. Neveu MJ, Hully JR, Babcock KL, Vaughan J, Hertzberg EL, Nicholson BJ, et al. Proliferation-associated differences in the spatial and temporal expression of gap junction genes in rat liver. Hepatology 1995; 22: 202-12.
189. Baranova A, Ivanov D, Petrash N, Pestova A, Skoblov M, Kelmanson I, et al. The mammalian pannexin family is homologous to the invertebrate innexin gap junction proteins. Genomics 2004; 83: 706-16.
190. Crowther MA. Pathogenesis of atherosclerosis. Hematology Am Soc Hematol Educ Program 2005: 436-41.
191. Lamon BD, Hajjar DP. Inflammation at the molecular interface of atherogenesis: an anthropological journey. Am J Pathol 2008; 173: 1253-64.
192. Lusis AJ. Atherosclerosis. Nature 2000; 407: 233-41.
193. Evans WH, Martin PE. Gap junctions: structure and function (Review). Mol Membr Biol 2002; 19: 121-36.
194. Figueroa XF, Isakson BE, Duling BR. Connexins: gaps in our knowledge of vascular function. Physiology (Bethesda) 2004; 19: 277-84.
195. Haefliger JA, Nicod P, Meda P. Contribution of connexins to the function of the vascular wall. Cardiovasc Res 2004; 62: 345-56.
196. Severs NJ, Rothery S, Dupont E, Coppen SR, Yeh HI, Ko YS, et al. Immunocytochemical analysis of connexin expression in the healthy and diseased cardiovascular system. Microsc Res Tech 2001; 52: 301-22.
197. Toma I, Bansal E, Meer EJ, Kang JJ, Vargas SL, Peti-Peterdi J. Connexin 40 and ATP-dependent intercellular calcium wave in renal glomerular endothelial cells. Am J Physiol Regul Integr Comp Physiol 2008; 294: 1769-76.
198. Hill CE, Rummery N, Hickey H, Sandow SL. Heterogeneity in the distribution of vascular gap junctions and connexins: implications for function. Clin Exp Pharmacol Physiol 2002; 29: 620-5.
199. van Kempen MJ, Jongsma HJ. Distribution of connexin37, connexin40 and connexin43 in the aorta and coronary artery of several mammals. Histochem Cell Biol 1999; 112: 479-86.
200. van Kempen MJ, ten Velde I, Wessels A, Oosthoek PW, Gros D, Jongsma HJ, et al. Differential connexin distribution accommodates cardiac function in different species. Microsc Res Tech 1995; 31: 420-36.
201. Blackburn JP, Peters NS, Yeh HI, Rothery S, Green CR, Severs NJ. Upregulation of connexin43 gap junctions during early stages of human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1995; 15: 1219-28.
202. Haefliger JA, Meda P. Chronic hypertension alters the expression of Cx43 in cardiovascular muscle cells. Braz J Med Biol Res 2000; 33: 431-8.
203. Haefliger JA, Polikar R, Schnyder G, Burdet M, Sutter E, Pexieder T, et al. Connexin37 in normal and pathological development of mouse heart and great arteries. Dev Dyn 2000; 218: 331-44.
204. Kwak BR, Mulhaupt F, Veillard N, Gros DB, Mach F. Altered pattern of vascular connexin expression in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2002; 22: 225-30.
205. Polacek D, Lal R, Volin MV, Davies PF. Gap junctional communication between vascular cells. Induction of connexin43 messenger RNA in macrophage foam cells of atherosclerotic lesions. Am J Pathol 1993; 142: 593-606.
206. Polacek D, Bech F, McKinsey JF, Davies PF. Connexin43 gene expression in the rabbit arterial wall: effects of hypercholesterolemia, balloon injury and their combination. J Vasc Res 1997; 34: 19-30.
207. Yeh HI, Lupu F, Dupont E, Severs NJ. Upregulation of connexin43 gap junctions between smooth muscle cells after balloon catheter injury in the rat carotid artery. Arterioscler Thromb Vasc Biol 1997; 17: 3174-84.
208. Chadjichristos CE, Derouette JP, Kwak BR. Connexins in atherosclerosis. Adv Cardiol 2006; 42: 255-67.
209. Chadjichristos CE, Kwak BR. Connexins: new genes in atherosclerosis. Ann Med 2007; 39: 402-11.
210. Chanson M, Kwak BR. Connexin37: a potential modifier gene of inflammatory disease. J Mol Med 2007; 85: 787-95.
211. Brisset AC, Isakson BE, Kwak BR. Connexins in Vascular Physiology and Pathology. Antioxid Redox Signal 2008; In press.
212. Contreras JE, Sáez JC, Bukauskas FF, Bennett MV. Gating and regulation of connexin 43 (Cx43) hemichannels. Proc Natl Acad Sci USA 2003; 100: 11388-93.
213. Hanner F, von Maltzahn J, Maxeiner S, Toma I, Sipos A, Kruger O, et al. Connexin45 is expressed in the juxtaglomerular apparatus and is involved in the regulation of renin secretion and blood pressure. Am J Physiol Regul Integr Comp Physiol 2008; 295: 371-80.
214. Young RC, Schumann R, Zhang P. The signaling mechanisms of long distance intercellular calcium waves (far waves) in cultured human uterine myocytes. J Muscle Res Cell Motil 2002; 23: 279-84.
215. Schalper KA, Palacios-Prado N, Orellana JA, Sáez JC. Currently used methods for identification and characterization of hemichannels. Cell Commun Adhes 2008; 15: 207-18.
216. 2 on the circular and longitudinal muscles of the guinea-pig isolated colon. Prostaglandins 1991; 42: 579-86.
217. Furumoto T, Saito N, Dong J, Mikami T, Fujii S, Kitabatake A. Association of cardiovascular risk factors and endothelial dysfunction in japanese hypertensive patients: implications for early atherosclerosis. Hypertens Res 2002; 25: 475-80.
218. Landmesser U, Hornig B, Drexler H. Endothelial function: a critical determinant in atherosclerosis? Circulation 2004; 109: 27-33.
219. Zhao LL, Chen HJ, Chen JZ, Yu M, Ni YL, Zhang WF. Losartan reduced connexin43 expression in left ventricular myocardium of spontaneously hypertensive rats. J Zhejiang Univ Sci B 2008; 9: 448-54.
220. Gabriels JE, Paul DL. Connexin43 is highly localized to sites of disturbed flow in rat aortic endothelium but connexin37 and connexin40 are more uniformly distributed. Circ Res 1998; 83: 636-43.
221. Johnson TL, Nerem RM. Endothelial connexin 37, connexin 40, and connexin 43 respond uniquely to substrate and shear stress. Endothelium 2007; 14: 215-26.
222. Kwak BR, Silacci P, Stergiopulos N, Hayoz D, Meda P. Shear stress and cyclic circumferential stretch, but not pressure, alter connexin43 expression in endothelial cells. Cell Commun Adhes 2005; 12: 261-70.
223. DePaola N, Davies PF, Pritchard WF, Jr., Florez L, Harbeck N, Polacek DC. Spatial and temporal regulation of gap junction connexin43 in vascular endothelial cells exposed to controlled disturbed flows in vitro. Proc Natl Acad Sci USA 1999; 96: 3154-9.
224. Arcuino G, Lin JH, Takano T, Liu C, Jiang L, Gao Q, et al. Intercellular calcium signaling mediated by point-source burst release of ATP. Proc Natl Acad Sci USA 2002; 99: 9840-5.
225. Lisak RP, Benjamins JA, Bealmear B, Nedelkoska L, Yao B, Land S, et al. Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for glial and neural-related molecules in central nervous system mixed glial cell cultures: neurotrophins, growth factors and structural proteins. J Neuroinflammation 2007; 4: 30.
226. Sharrow AC, Li Y, Micsenyi A, Griswold RD, Wells A, Monga SS, et al. Modulation of osteoblast gap junction connectivity by serum, TNFα, and TRAIL. Exp Cell Res 2008; 314: 297-308.
227. Eugenín EA, Brañes MC, Berman JW, Sáez JC. TNF-α plus IFN-γ induce connexin43 expression and formation of gap junctions between human monocytes/macrophages that enhance physiological responses. J Immunol 2003; 170: 1320-8.
228. Thurberg BL, Collins T. The nuclear factor-kappa B/inhibitor of kappa B autoregulatory system and atherosclerosis. Curr Opin Lipidol 1998; 9: 387-96.
229. Rama A, Matsushita T, Charolidi N, Rothery S, Dupont E, Severs NJ. Up-regulation of connexin43 correlates with increased synthetic activity and enhanced contractile differentiation in TGF-β-treated human aortic smooth muscle cells. Eur J Cell Biol 2006; 85: 375-86.
230. Navab M, Liao F, Hough GP, Ross LA, Van Lenten BJ, Rajavashisth TB, et al. Interaction of monocytes with cocultures of human aortic wall cells involves interleukins 1 and 6 with marked increases in connexin43 message. J Clin Invest 1991; 87: 1763-72.
231. Pelegrin P, Barroso-Gutierrez C, Surprenant A. P2X7 receptor differentially couples to distinct release pathways for IL-1β in mouse macrophage. J Immunol 2008; 180: 7147-57.
232. Lasky LA. A 'roll' in acute inflammation. Curr Biol 1993; 3: 680-2.
233. Ferns GA, Forster L, Stewart-Lee A, Nourooz-Zadeh J, Anggard EE. Probucol inhibits mononuclear cell adhesion to vascular endothelium in the cholesterol-fed rabbit. Atherosclerosis 1993; 100: 171-81.
234. Wong CW, Christen T, Roth I, Chadjichristos CE, Derouette JP, Foglia BF, et al. Connexin37 protects against atherosclerosis by regulating monocyte adhesion. Nat Med 2006; 12: 950-4.
235. Brañes MC, Contreras JE, Sáez JC. Activation of human polymorphonuclear cells induces formation of functional gap junctions and expression of connexins. Med Sci Monit 2002; 8: 313-23.
236. Eltzschig HK, Eckle T, Mager A, Kuper N, Karcher C, Weissmuller T, et al. ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function. Circ Res 2006; 99: 1100-8.
237. Kanczuga-Koda L, Sulkowski S, Koda M, Sobaniec-Lotowska M, Sulkowska M. Expression of connexins 26, 32 and 43 in the human colon - an immunohistochemical study. Folia Histochem Cytobiol 2004; 42: 203-7.
238. Clair C, Combettes L, Pierre F, Sansonetti P, Tran Van Nhieu G. Extracellular-loop peptide antibodies reveal a predominant hemichannel organization of connexins in polarized intestinal cells. Exp Cell Res 2008; 314: 1250-65.
239. Tran Van Nhieu G, Clair C, Bruzzone R, Mesnil M, Sansonetti P, Combettes L. Connexin-dependent inter-cellular communication increases invasion and dissemination of Shigella in epithelial cells. Nat Cell Biol 2003; 5: 720-6.
240. Velasquez Almonacid LA, Tafuri S, Dipineto L, Matteoli G, Fiorillo E, Morte RD, et al. Role of connexin-43 hemichannels in the pathogenesis of Yersinia enterocolitica. Vet J 2008; In press.
241. Dietzman DE, Fischer GW, Schoenknecht FD. Neonatal Escherichia coli septicemia - bacterial counts in blood. J Pediatr 1974; 85: 128-30.
242. Ring A, Weiser JN, Tuomanen EI. Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway. J Clin Invest 1998; 102: 347-60.
243. Bannerman DD, Fitzpatrick MJ, Anderson DY, Bhattacharjee AK, Novitsky TJ, Hasday JD, et al. Endotoxin-neutralizing protein protects against endotoxin-induced endothelial barrier dysfunction. Infect Immun 1998; 66: 1400-7.
244. Doran KS, Liu GY, Nizet V. Group B streptococcal β-hemolysin/ cytolysin activates neutrophil signaling pathways in brain endothelium and contributes to development of meningitis. J Clin Invest 2003; 112: 736-44.
245. Freyer D, Manz R, Ziegenhorn A, Weih M, Angstwurm K, Docke WD, et al. Cerebral endothelial cells release TNF-α after stimulation with cell walls of Streptococcus pneumoniae and regulate inducible nitric oxide synthase and ICAM-1 expression via autocrine loops. J Immunol 1999; 163: 4308-14.
246. Vandamme W, Braet K, Cabooter L, Leybaert L. Tumour necrosis factor alpha inhibits purinergic calcium signalling in blood-brain barrier endothelial cells. J Neurochem 2004; 88: 411-21.
247. Braet K, Aspeslagh S, Vandamme W, Willecke K, Martin PE, Evans WH, et al. Pharmacological sensitivity of ATP release triggered by photoliberation of inositol-1,4,5-trisphosphate and zero extracellular calcium in brain endothelial cells. J Cell Physiol 2003; 197: 205-13.
248. Braet K, Vandamme W, Martin PE, Evans WH, Leybaert L. Photoliberating inositol-1,4,5-trisphosphate triggers ATP release that is blocked by the connexin mimetic peptide gap 26. Cell Calcium 2003; 33: 37-48.
249. Nagasawa K, Chiba H, Fujita H, Kojima T, Saito T, Endo T, et al. Possible involvement of gap junctions in the barrier function of tight junctions of brain and lung endothelial cells. J Cell Physiol 2006; 208: 123-32.
250. Veliz LP, Gonzalez FG, Duling BR, Sáez JC, Boric MP. Functional role of gap junctions in cytokine-induced leukocyte adhesion to endothelium in vivo. Am J Physiol Heart Circ Physiol 2008; 295: 1056-66.
251. Haddad L, El Hajj H, Abou-Merhi R, Kfoury Y, Mahieux R, El-Sabban M, et al. KSHV-transformed primary effusion lymphoma cells induce a VEGF-dependent angiogenesis and establish functional gap junctions with endothelial cells. Leukemia 2008; 22: 826-34.
252. Bondarev I, Vine A, Bertram JS. Cloning and functional expression of a novel human connexin-25 gene. Cell Commun Adhes 2001; 8: 167-71.
253. Cruciani V, Mikalsen SO. The connexin gene family in mammals. Biol Chem 2005; 386: 325-32.
254. Scott DA, Kraft ML, Stone EM, Sheffield VC, Smith RJ. Connexin mutations and hearing loss. Nature 1998; 391: 32.
255. Kelley PM, Harris DJ, Comer BC, Askew JW, Fowler T, Smith SD, et al. Novel mutations in the connexin 26 gene (GJB2) that cause autosomal recessive (DFNB1) hearing loss. Am J Hum Genet 1998; 62: 792-99.
256. Cohn ES, Kelley PM. Clinical phenotype and mutations in connexin 26 ( DFNB1/GJB2), the most common cause of childhood hearing loss. Am J Med Genet 1999; 89: 130-6.
257. Estivill X, Fortina P, Surrey S, Rabionet R, Melchionda S, D'Agruma L, et al. Connexin-26 mutations in sporadic and inherited sensorineural deafness. Lancet 1998; 351: 394-8.
258. Murgia A, Orzan E, Polli R, Martella M, Vinanzi C, Leonardi E, et al. Cx26 deafness: mutation analysis and clinical variability. J Med Genet 1999; 36: 829-32.
259. Abe S, Usami S, Shinkawa H, Kelley PM, Kimberling WJ. Prevalent connexin 26 gene (GJB2) mutations in Japanese. J Med Genet 2000; 37: 41-3.
260. Park HJ, Hahn SH, Chun YM, Park K, Kim HN. Connexin26 mutations associated with nonsyndromic hearing loss. Laryngoscope 2000; 110: 1535-8.
261. Wilcox SA, Saunders K, Osborn AH, Arnold A, Wunderlich J, Kelly T, et al. High frequency hearing loss correlated with mutations in the GJB2 gene. Hum Genet 2000; 106: 399-405.
262. Oliveira CA, Maciel-Guerra AT, Sartorato EL. Deafness resulting from mutations in the GJB2 (connexin 26) gene in Brazilian patients. Clin Genet 2002; 61: 354-8.
263. Bason L, Dudley T, Lewis K, Shah U, Potsic W, Ferraris A, et al. Homozygosity for the V37I Connexin 26 mutation in three unrelated children with sensorineural hearing loss. Clin Genet 2002; 61: 459-64.
264. Harris KC, Erbe CB, Firszt JB, Flanary VA, Wackym PA. A novel connexin 26 compound heterozygous mutation results in deafness. Laryngoscope 2002; 112: 1159-62.
265. Lopponen T, Vaisanen ML, Luotonen M, Allinen M, Uusimaa J, Lindholm P, et al. Connexin 26 mutations and nonsyndromic hearing impairment in northern Finland. Laryngoscope 2003; 113: 1758-63.
266. Frei K, Lucas T, Ramsebner R, Schofer C, Baumgartner WD, Weipoltshammer K, et al. A novel connexin 26 mutation associated with autosomal recessive sensorineural deafness. Audiol Neurootol 2004; 9: 47-50.
267. Leshinsky-Silver E, Berman Z, Vinkler C, Yannov-Sharav M, Lev D. A novel missense mutation in the Connexin 26 gene associated with autosomal recessive sensorineural deafness. Hear Res 2005; 202: 258-61.
268. Alvarez A, del Castillo I, Villamar M, Aguirre LA, Gonzalez-Neira A, Lopez-Nevot A, et al. High prevalence of the W24X mutation in the gene encoding connexin-26 (GJB2) in Spanish Romani (gypsies) with autosomal recessive non-syndromic hearing loss. Am J Med Genet A 2005; 137: 255-8.
269. Ravecca F, Berrettini S, Forli F, Marcaccini M, Casani A, Baldinotti F, et al. Cx26 gene mutations in idiopathic progressive hearing loss. J Otolaryngol 2005; 34: 126-34.
270. Wang YC, Kung CY, Su MC, Su CC, Hsu HM, Tsai CC, et al. Mutations of Cx26 gene (GJB2) for prelingual deafness in Taiwan. Eur J Hum Genet 2002; 10: 495-8.
271. Pampanos A, Economides J, Iliadou V, Neou P, Leotsakos P, Voyiatzis N, et al. Prevalence of GJB2 mutations in prelingual deafness in the Greek population. Int J Pediatr Otorhinolaryngol 2002; 65: 101-8.
272. Kupka S, Braun S, Aberle S, Haack B, Ebauer M, Zeissler U, et al. Frequencies of GJB2 mutations in German control individuals and patients showing sporadic non-syndromic hearing impairment. Hum Mutat 2002; 20: 77-8.
273. Ohtsuka A, Yuge I, Kimura S, Namba A, Abe S, Van Laer L, et al. GJB2 deafness gene shows a specific spectrum of mutations in Japan, including a frequent founder mutation. Hum Genet 2003; 112: 329-33.
274. Erbe CB, Harris KC, Runge-Samuelson CL, Flanary VA, Wackym PA. Connexin 26 and connexin 30 mutations in children with non-syndromic hearing loss. Laryngoscope 2004; 114: 607-11.
275. Yang JJ, Huang SH, Chou KH, Liao PJ, Su CC, Li SY. Identification of mutations in members of the connexin gene family as a cause of nonsyndromic deafness in Taiwan. Audiol Neurootol 2007; 12: 198-208.
276. Kelsell DP, Dunlop J, Stevens HP, Lench NJ, Liang JN, Parry G, et al. Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature 1997; 387: 80-3.
277. Richard G, White TW, Smith LE, Bailey RA, Compton JG, Paul DL, et al. Functional defects of Cx26 resulting from a heterozygous missense mutation in a family with dominant deaf-mutism and palmoplantar keratoderma. Hum Genet 1998; 103: 393-9.
278. Kenna MA, Wu BL, Cotanche DA, Korf BR, Rehm HL. Connexin 26 studies in patients with sensorineural hearing loss. Arch Otolaryngol Head Neck Surg 2001; 127: 1037-42.
279. Loffler J, Nekahm D, Hirst-Stadlmann A, Gunther B, Menzel HJ, Utermann G, et al. Sensorineural hearing loss and the incidence of Cx26 mutations in Austria. Eur J Hum Genet 2001; 9: 226-30.
280. Xiao ZA, Xie DH. GJB2 (Cx26) gene mutations in Chinese patients with congenital sensorineural deafness and a report of one novel mutation. Chin Med J (Engl) 2004; 117: 1797-801.
281. Morle L, Bozon M, Alloisio N, Latour P, Vandenberghe A, Plauchu H, et al. A novel C202F mutation in the connexin26 gene (GJB2) associated with autosomal dominant isolated hearing loss. J Med Genet 2000; 37: 368-70.
282. Tekin M, Arnos KS, Xia XJ, Oelrich MK, Liu XZ, Nance WE, et al. W44C mutation in the connexin 26 gene associated with dominant non-syndromic deafness. Clin Genet 2001; 59: 269-73.
283. Janecke AR, Nekahm D, Loffler J, Hirst-Stadlmann A, Muller T, Utermann G. De novo mutation of the connexin 26 gene associated with dominant non-syndromic sensorineural hearing loss. Hum Genet 2001; 108: 269-70.
284. D'Andrea P, Veronesi V, Bicego M, Melchionda S, Zelante L, Di Iorio E, et al. Hearing loss: frequency and functional studies of the most common connexin26 alleles. Biochem Biophys Res Commun 2002; 296: 685-91.
285. Melchionda S, Bicego M, Marciano E, Franze A, Morgutti M, Bortone G, et al. Functional characterization of a novel Cx26 (T55N) mutation associated to non-syndromic hearing loss. Biochem Biophys Res Commun 2005; 337: 799-805.
286. Maestrini E, Korge BP, Ocana-Sierra J, Calzolari E, Cambiaghi S, Scudder PM, et al. A missense mutation in connexin26, D66H, causes mutilating keratoderma with sensorineural deafness (Vohwinkel's syndrome) in three unrelated families. Hum Mol Genet 1999; 8: 1237-43.
287. Kelsell DP, Wilgoss AL, Richard G, Stevens HP, Munro CS, Leigh IM. Connexin mutations associated with palmoplantar keratoderma and profound deafness in a single family. Eur J Hum Genet 2000; 8: 469-72.
288. Heathcote K, Syrris P, Carter ND, Patton MA. A connexin 26 mutation causes a syndrome of sensorineural hearing loss and palmoplantar hyperkeratosis (MIM 148350). J Med Genet 2000; 37: 50-1.
289. Uyguner O, Tukel T, Baykal C, Eris H, Emiroglu M, Hafiz G, et al. The novel R75Q mutation in the GJB2 gene causes autosomal dominant hearing loss and palmoplantar keratoderma in a Turkish family. Clin Genet 2002; 62: 306-9.
290. Snoeckx RL, Huygen PL, Feldmann D, Marlin S, Denoyelle F, Waligora J, et al. GJB2 mutations and degree of hearing loss: a multicenter study. Am J Hum Genet 2005; 77: 945-57.
291. Richard G, Rouan F, Willoughby CE, Brown N, Chung P, Ryynanen M, et al. Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome. Am J Hum Genet 2002; 70: 1341-8.
292. Yotsumoto S, Hashiguchi T, Chen X, Ohtake N, Tomitaka A, Akamatsu H, et al. Novel mutations in GJB2 encoding connexin-26 in Japanese patients with keratitis-ichthyosis-deafness syndrome. Br J Dermatol 2003; 148: 649-53.
293. Mazereeuw-Hautier J, Bitoun E, Chevrant-Breton J, Man SY, Bodemer C, Prins C, et al. Keratitis-ichthyosis-deafness syndrome: disease expression and spectrum of connexin 26 (GJB2) mutations in 14 patients. Br J Dermatol 2007; 156: 1015-9.
294. Richard G, Brown N, Ishida-Yamamoto A, Krol A. Expanding the phenotypic spectrum of Cx26 disorders: Bart-Pumphrey syndrome is caused by a novel missense mutation in GJB2. J Invest Dermatol 2004; 123: 856-63.
295. Alexandrino F, Sartorato EL, Marques-de-Faria AP, Steiner CE. G59S mutation in the GJB2 (connexin 26) gene in a patient with Bart-Pumphrey syndrome. Am J Med Genet A 2005; 136: 282-4.
296. Houang M, Gourmelen M, Moatti L, Le BY, Garabedian EN, Denoyelle F. Hypogonadotrophic hypogonadism associated with prelingual deafness due to a connexin 26 gene mutation. J Pediatr Endocrinol Metab 2002; 15: 219-23.
297. Grifa A, Wagner CA, D'Ambrosio L, Melchionda S, Bernardi F, Lopez-Bigas N, et al. Mutations in GJB6 cause nonsyndromic autosomal dominant deafness at DFNA3 locus. Nat Genet 1999; 23: 16-8.
298. del Castillo I, Villamar M, Moreno-Pelayo MA, del Castillo FJ, Alvarez A, Telleria D, et al. A deletion involving the connexin 30 gene in nonsyndromic hearing impairment. N Engl J Med 2002; 346: 243-9.
299. Common JE, Becker D, Di WL, Leigh IM, O'Toole EA, Kelsell DP. Functional studies of human skin disease- and deafness-associated connexin 30 mutations. Biochem Biophys Res Commun 2002; 298: 651-6.
300. Zhang XJ, Chen JJ, Yang S, Cui Y, Xiong XY, He PP, et al. A mutation in the connexin 30 gene in Chinese Han patients with hidrotic ectodermal dysplasia. J Dermatol Sci 2003; 32: 11-7.
301. Jan AY, Amin S, Ratajczak P, Richard G, Sybert VP. Genetic heterogeneity of KID syndrome: identification of a Cx30 gene (GJB6) mutation in a patient with KID syndrome and congenital atrichia. J Invest Dermatol 2004; 122: 1108-13.
302. Macari F, Landau M, Cousin P, Mevorah B, Brenner S, Panizzon R, et al. Mutation in the gene for connexin 30.3 in a family with erythrokeratodermia variabilis. Am J Hum Genet 2000; 67: 1296-301.
303. Richard G, Smith LE, Bailey RA, Itin P, Hohl D, Epstein EH, Jr., et al. Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis. Nat Genet 1998; 20: 366-9.
304. Wilgoss A, Leigh IM, Barnes MR, Dopping-Hepenstal P, Eady RA, Walter JM, et al. Identification of a novel mutation R42P in the gap junction protein β-3 associated with autosomal dominant erythrokeratoderma variabilis. J Invest Dermatol 1999; 113: 1119-22.
305. Morley SM, White MI, Rogers M, Wasserman D, Ratajczak P, McLean WH, et al. A new, recurrent mutation of GJB3 (Cx31) in erythrokeratodermia variabilis. Br J Dermatol 2005; 152: 1143-8.
306. Xia JH, Liu CY, Tang BS, Pan Q, Huang L, Dai HP, et al. Mutations in the gene encoding gap junction protein β-3 associated with autosomal dominant hearing impairment. Nat Genet 1998; 20: 370-3.
307. Liu XZ, Xia XJ, Xu LR, Pandya A, Liang CY, Blanton SH, et al. Mutations in connexin31 underlie recessive as well as dominant non-syndromic hearing loss. Hum Mol Genet 2000; 9: 63-7.
308. Nielsen PA, Beahm DL, Giepmans BN, Baruch A, Hall JE, Kumar NM. Molecular cloning, functional expression, and tissue distribution of a novel human gap junction-forming protein, connexin-31.9. Interaction with zona occludens protein-1. J Biol Chem 2002; 277: 38272-83.
309. White TW, Srinivas M, Ripps H, Trovato-Salinaro A, Condorelli DF, Bruzzone R. Virtual cloning, functional expression, and gating analysis of human connexin31.9. Am J Physiol Cell Physiol 2002; 283: 960-70.
310. Bergoffen J, Scherer SS, Wang S, Scott MO, Bone LJ, Paul DL, et al. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 1993; 262: 2039-42.
311. Bruzzone R, White TW, Paul DL. Expression of chimeric connexins reveals new properties of the formation and gating behavior of gap junction channels. J Cell Sci 1994; 107: 955-67.
312. Fairweather N, Bell C, Cochrane S, Chelly J, Wang S, Mostacciuolo ML, et al. Mutations in the connexin 32 gene in X-linked dominant Charcot-Marie-Tooth disease (CMTX1). Hum Mol Genet 1994; 3: 29-34.
313. Ionasescu V, Searby C, Ionasescu R. Point mutations of the connexin32 (GJB1) gene in X-linked dominant Charcot-Marie-Tooth neuropathy. Hum Mol Genet 1994; 3: 355-8.
314. Ionasescu V, Searby C, Ionasescu R, Meschino W. New point mutations and deletions of the connexin 32 gene in X-linked Charcot-Marie-Tooth neuropathy. Neuromuscul Disord 1995; 5: 297-9.
315. Ionasescu V, Ionasescu R, Searby C. Correlation between connexin 32 gene mutations and clinical phenotype in X-linked dominant Charcot-Marie-Tooth neuropathy. Am J Med Genet 1996; 63: 486-91.
316. Nelis E, Simokovic S, Timmerman V, Lofgren A, Backhovens H, De Jonghe P, et al. Mutation analysis of the connexin 32 (Cx32) gene in Charcot-Marie-Tooth neuropathy type 1: identification of five new mutations. Hum Mutat 1997; 9: 47-52.
317. Rouger H, LeGuern E, Birouk N, Gouider R, Tardieu S, Plassart E, et al. Charcot-Marie-Tooth disease with intermediate motor nerve conduction velocities: characterization of 14 Cx32 mutations in 35 families. Hum Mutat 1997; 10: 443-52.
318. Silander K, Meretoja P, Pihko H, Juvonen V, Issakainen J, Aula P, et al. Screening for connexin 32 mutations in Charcot-Marie-Tooth disease families with possible X-linked inheritance. Hum Genet 1997; 100: 391-7.
319. Meggouh F, Benomar A, Rouger H, Tardieu S, Birouk N, Tassin J, et al. The first de novo mutation of the connexin 32 gene associated with X linked Charcot-Marie-Tooth disease. J Med Genet 1998; 35: 251-2.
320. Birouk N, LeGuern E, Maisonobe T, Rouger H, Gouider R, Tardieu S, et al. X-linked Charcot-Marie-Tooth disease with connexin 32 mutations: clinical and electrophysiologic study. Neurology 1998; 50: 1074-82.
321. Silander K, Meretoja P, Juvonen V, Ignatius J, Pihko H, Saarinen A, et al. Spectrum of mutations in Finnish patients with Charcot-Marie-Tooth disease and related neuropathies. Hum Mutat 1998; 12: 59-68.
322. Flagiello L, Cirigliano V, Strazzullo M, Cappa V, Ciccodicola A, D'Esposito M, et al. Mutation in the nerve-specific 5′non-coding region of Cx32 gene and absence of specific mRNA in a CMTX1 Italian family. Mutations in brief no. 195. Online. Hum Mutat 1998; 12: 361.
323. Bahr M, Andres F, Timmerman V, Nelis ME, Van Broeckhoven C, Dichgans J. Central visual, acoustic, and motor pathway involvement in a Charcot-Marie-Tooth family with an Asn205Ser mutation in the connexin 32 gene. J Neurol Neurosurg Psychiatry 1999; 66: 202-6.
324. Mersiyanova IV, Ismailov SM, Polyakov AV, Dadali EL, Fedotov VP, Nelis E, et al. Screening for mutations in the peripheral myelin genes PMP22, MPZ and Cx32 (GJB1) in Russian Charcot-Marie-Tooth neuropathy patients. Hum Mutat 2000; 15: 340-7.
325. Di Iorio G, Cappa V, Ciccodicola A, Sampaolo S, Ammendola A, Sanges G, et al. A new de novo mutation of the connexin-32 gene in a patient with X-linked Charcot-Marie-Tooth type 1 disease. Neurol Sci 2000; 21: 109-12.
326. Seeman P, Mazanec R, Ctvrteckova M, Smilkova D. Charcot-Marie-Tooth type X: A novel mutation in the Cx32 gene with central conduction slowing. Int J Mol Med 2001; 8: 461-8.
327. Kuntzer T, Dunand M, Schorderet DF, Vallat JM, Hahn AF, Bogousslavsky J. Phenotypic expression of a Pro 87 to Leu mutation in the connexin 32 gene in a large Swiss family with Charcot-Marie-Tooth neuropathy. J Neurol Sci 2003; 207: 77-86.
328. Hanemann CO, Bergmann C, Senderek J, Zerres K, Sperfeld AD. Transient, recurrent, white matter lesions in X-linked Charcot-Marie-Tooth disease with novel connexin 32 mutation. Arch Neurol 2003; 60: 605-9.
329. Sahin N, Tan M, Kalay E, Calapoglu M, Karaguzel A. Connexin 32 mutation in a Turkish family with X-linked Charcot-Marie-Tooth disease. Int J Neurosci 2003; 113: 777-85.
330. Kleopa KA, Zamba-Papanicolaou E, Alevra X, Nicolaou P, Georgiou DM, Hadjisavvas A, et al. Phenotypic and cellular expression of two novel connexin32 mutations causing CMT1X. Neurology 2006; 66: 396-402.
331. Murru MR, Vannelli A, Marrosu G, Cocco E, Corongiu D, Tranquilli S, et al. A novel Cx32 mutation causes X-linked Charcot-Marie-Tooth disease with brainstem involvement and brain magnetic resonance spectroscopy abnormalities. Neurol Sci 2006; 27: 18-23.
332. Song S, Zhang Y, Chen B, Wang M, Wang Y, Yan M, et al. Mutation frequency for Charcot-Marie-Tooth disease type 1 in the Chinese population is similar to that in the global ethnic patients. Genet Med 2006; 8: 532-5.
333. Stojkovic T, Latour P, Vandenberghe A, Hurtevent JF, Vermersch P. Sensorineural deafness in X-linked Charcot-Marie-Tooth disease with connexin 32 mutation (R142Q). Neurology 1999; 52: 1010-4.
334. Mas C, Taske N, Deutsch S, Guipponi M, Thomas P, Covanis A, et al. Association of the connexin36 gene with juvenile myoclonic epilepsy. J Med Genet 2004; 41: 93.
335. Hempelmann A, Heils A, Sander T. Confirmatory evidence for an association of the connexin-36 gene with juvenile myoclonic epilepsy. Epilepsy Res 2006; 71: 223-8.
336. Makita N, Sasaki K, Groenewegen WA, Yokota T, Yokoshiki H, Murakami T, et al. Congenital atrial standstill associated with coinheritance of a novel SCN5A mutation and connexin 40 polymorphisms. Heart Rhythm 2005; 2: 1128-34.
337. Britz-Cunningham SH, Shah MM, Zuppan CW, Fletcher WH. Mutations of the Connexin43 gap-junction gene in patients with heart malformations and defects of laterality. N Engl J Med 1995; 332: 1323-9.
338. van Steensel MA, Spruijt L, van der Burgt I, Bladergroen RS, Vermeer M, Steijlen PM, et al. A 2-bp deletion in the GJA1 gene is associated with oculo-dento-digital dysplasia with palmoplantar keratoderma. Am J Med Genet A 2005; 132: 171-4.
339. Itro A, Marra A, Urciuolo V, Difalco P, Amodio A. Oculodentodigital dysplasia. A case report. Minerva Stomatol 2005; 54: 453-9.
340. Nemeth L, Maddur S, Puri P. Immunolocalization of the gap junction protein Connexin43 in the interstitial cells of Cajal in the normal and Hirschsprung's disease bowel. J Pediatr Surg 2000; 35: 823-8.
341. Vis JC, Nicholson LF, Faull RL, Evans WH, Severs NJ, Green CR. Connexin expression in Huntington's diseased human brain. Cell Biol Int 1998; 22: 837-47.
342. Mackay D, Ionides A, Kibar Z, Rouleau G, Berry V, Moore A, et al. Connexin46 mutations in autosomal dominant congenital cataract. Am J Hum Genet 1999; 64: 1357-64.
343. Jiang H, Jin Y, Bu L, Zhang W, Liu J, Cui B, et al. A novel mutation in GJA3 (connexin46) for autosomal dominant congenital nuclear pulverulent cataract. Mol Vis 2003; 9: 579-83.
344. Bugiani M, Al Shahwan S, Lamantea E, Bizzi A, Bakhsh E, Moroni I, et al. GJA12 mutations in children with recessive hypomyelinating leukoencephalopathy. Neurology 2006; 67: 273-9.
345. Orthmann-Murphy JL, Enriquez AD, Abrams CK, Scherer SS. Loss-of-function GJA12/Connexin47 mutations cause Pelizaeus-Merzbacher-like disease. Mol Cell Neurosci 2007; 34: 629-41.
346. Shiels A, Mackay D, Ionides A, Berry V, Moore A, Bhattacharya S. A missense mutation in the human connexin50 gene (GJA8) underlies autosomal dominant "zonular pulverulent" cataract, on chromosome 1q. Am J Hum Genet 1998; 62: 526-32.